Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.

ABSTRACT:

SUBMITTER: Elias EE 

PROVIDER: S-EPMC6165796 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature